Logo

American Heart Association

  45
  0


Final ID: FR605

Efficacy and Safety of Renal Denervation in Resistant Hypertension: A Meta-Analysis of Contemporary Randomized Controlled Trials (2010-2025)

Abstract Body: Background:
Resistant hypertension (RH)—defined as uncontrolled blood pressure (BP) despite adherence to three or more antihypertensive medications—remains a major contributor to cardiovascular risk. Over the past decade, catheter-based renal denervation (RDN) has evolved with improvements in ablation techniques and patient selection. We conducted a meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy and safety of RDN in patients with RH.

Methods:
We systematically searched PubMed, Embase, and Cochrane Central for randomized controlled trials (RCTs) published from January 2010 to March 2025 that compared RDN to standard or optimized medical therapy. Two reviewers independently screened studies, extracted data and assessed risk of bias. A random-effects meta-analysis was performed. Primary outcomes were change in office and 24-hour ambulatory systolic BP. Secondary outcomes included major adverse cardiovascular events (MACE), renal function (eGFR), antihypertensive medication burden, and procedural safety. Heterogeneity was assessed and sensitivity analyses were conducted based on device type and follow-up duration.

Results:
18 RCTs enrolling a total of 4,215 patients met inclusion criteria. RDN significantly reduced office systolic BP (mean difference [MD]: -9.2 mmHg; 95% CI: -11.0 to -7.4; I2=57%; p<0.001) and 24-hour ambulatory systolic BP (MD: -7.1 mmHg; 95% CI: -8.3 to -5.9; I2=48%; p<0.001). A 25% relative reduction in MACE was observed with RDN compared to control (risk ratio [RR]: 0.75; 95% CI: 0.62–0.90; p=0.003; I2=21%). RDN also led to a notable reduction in medication burden (MD: -1.4 antihypertensives; 95% CI: -1.9 to -0.9; p<0.001). No significant differences were seen in procedural complications (RR: 1.03; 95% CI: 0.86–1.22; p=0.74) or decline in eGFR (MD: -0.6 mL/min/1.73 m2; 95% CI: -1.4 to +0.2; p=0.13). Among trials with ≥12 months follow-up, BP-lowering effects were sustained over time.

Conclusions:
RDN appears to be a safe and effective adjunct for lowering BP in patients with resistant hypertension. It is associated with meaningful reductions in systolic BP, fewer cardiovascular events, and a reduced need for antihypertensive medications, without compromising renal function or procedural safety. Ongoing large-scale studies are warranted to determine long-term benefits, cost-effectiveness, and real-world applicability.

Keywords:
Renal denervation, resistant hypertension, randomized controlled trials
  • Patel, Kaushal  ( NYMC/ St. Mary St. Clare , Denville , New Jersey , United States )
  • Patel, Nirmit  ( NYMC Saint Clare Hospital , Parsippany , New Jersey , United States )
  • Patel, Gaurav  ( Saint Micheals Medical Center , Newark , New Jersey , United States )
  • V Ganesan, Ajitha  ( NYMC/ St. Mary St. Clare , Denville , New Jersey , United States )
  • Adrejiya, Parth  ( Wellstar Health System , Griffin , Georgia , United States )
  • Panchal, Viraj  ( Smt NHL Municipal Medical College , Ahmedabad , Gujarat , India )
  • Prakash, Atul  ( St Marys General Hospital, Passaic , Cedar Grove , New Jersey , United States )
  • Author Disclosures:
    Kaushal Patel: DO NOT have relevant financial relationships | Nirmit Patel: DO NOT have relevant financial relationships | Gaurav Patel: No Answer | AJITHA V GANESAN: No Answer | Parth Adrejiya: DO NOT have relevant financial relationships | Viraj Panchal: No Answer | Atul Prakash: No Answer
Meeting Info:
Session Info:

Poster Session 2 with Breakfast Reception

Friday, 09/05/2025 , 09:00AM - 10:30AM

Poster Session

More abstracts on this topic:
An Uncommon and Missed Diagnosis of Hypertension: Fibromuscular Dysplasia

Ketenci Melis, Fallahi Arzhang, Owlia Mina, Homayounrooz Forugh, Hsi David


A Large Animal Model of Persistent Atrial Fibrillation

Mostafizi Pouria, Goldman Steven, Moukabary Talal, Lefkowitz Eli, Ref Jacob, Daugherty Sherry, Grijalva Adrian, Cook Kyle Eric, Chinyere Ike, Lancaster Jordan, Koevary Jen

More abstracts from these authors:
Comparative Effectiveness and Safety of Left Atrial Appendage Occlusion Devices: A Comprehensive Systematic Review and Meta-Analysis

Patel Nirmit, Patel Kaushal, Bogati Sunil, Rawal Shalin, Agrawal Siddharth, Patel Gaurav, Prakash Atul

Recent Advances in Hypertension Management: Systematic review and Meta-Analysis of Emerging Therapies (2023-2025).

Patel Nirmit, Patel Kaushal, Patel Gaurav, Gandhi Darshan, Prakash Atul, Cheriyath Pramil

You have to be authorized to contact abstract author. Please, Login
Not Available